Whitehawk Therapeutics, Inc.
WHWK
$2.18
-$0.08-3.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -42.62% | -9.33% | 16.51% | 6.69% | 7.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -42.62% | -9.33% | 16.51% | 6.69% | 7.80% |
| Cost of Revenue | 66.96% | 54.96% | -9.43% | 4.48% | 10.45% |
| Gross Profit | -166.70% | -105.03% | 29.60% | -2.51% | -12.97% |
| SG&A Expenses | -2.87% | -7.70% | -11.41% | -17.51% | -20.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.57% | 28.38% | -10.32% | -5.70% | -4.62% |
| Operating Income | -70.58% | -41.09% | 18.89% | 9.89% | 8.76% |
| Income Before Tax | 74.68% | 84.08% | 140.12% | 3.15% | 2.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 74.68% | 84.08% | 140.12% | 3.15% | 2.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.68% | 84.08% | 140.12% | 3.15% | 2.72% |
| EBIT | -70.58% | -41.09% | 18.89% | 9.89% | 8.76% |
| EBITDA | -70.89% | -41.22% | 18.96% | 9.95% | 8.81% |
| EPS Basic | 106.53% | 97.60% | 106.40% | 3.57% | 3.12% |
| Normalized Basic EPS | 6.10% | 10.70% | 23.88% | 7.57% | 7.27% |
| EPS Diluted | 105.85% | 97.11% | 105.92% | 3.48% | 3.03% |
| Normalized Diluted EPS | 6.22% | 10.81% | 23.99% | 7.57% | 7.27% |
| Average Basic Shares Outstanding | 89.83% | 50.92% | 12.07% | 0.43% | 0.44% |
| Average Diluted Shares Outstanding | 90.10% | 51.19% | 12.34% | 0.43% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |